Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety and efficacy of PureGen Osteoprogenitor Cell Allograft in patients undergoing Posterior Lumbar or Transforaminal Interbody Fusion.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Alphatec Spine, Inc.
NCT02297256 · Lumbar Degenerative Disc Disease
NCT07363759 · Lumbar Degenerative Disease, Lumbar Degenerative Disc Disease, and more
NCT01689922 · Lumbar Degenerative Disc Disease
NCT01721889 · Lumbar Degenerative Disc Disease
Beverly Hills, California
Middleton, Connecticut
Greensboro, North Carolina
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions